Screening for epidermal growth factor receptor mutations in lung cancer R Rosell, T Moran, C Queralt, R Porta, F Cardenal, C Camps, M Majem, ... New England Journal of Medicine 361 (10), 958-967, 2009 | 2954 | 2009 |
PI3K/Akt signalling pathway and cancer JÁF Vara, E Casado, J de Castro, P Cejas, C Belda-Iniesta, ... Cancer treatment reviews 30 (2), 193-204, 2004 | 2790 | 2004 |
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study MC Garassino, BC Cho, JH Kim, J Mazières, J Vansteenkiste, H Lena, ... The Lancet Oncology 19 (4), 521-536, 2018 | 543 | 2018 |
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE … N Thatcher, FR Hirsch, AV Luft, A Szczesna, TE Ciuleanu, M Dediu, ... The lancet oncology 16 (7), 763-774, 2015 | 543 | 2015 |
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial AM Borobia, AJ Carcas, M Pérez-Olmeda, L Castaño, MJ Bertran, ... The Lancet 398 (10295), 121-130, 2021 | 423 | 2021 |
Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain) P Cejas, E Casado, C Belda-Iniesta, J De Castro, E Espinosa, A Redondo, ... Cancer Causes & Control 15, 707-719, 2004 | 243 | 2004 |
Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis A Isidoro, E Casado, A Redondo, P Acebo, E Espinosa, AM Alonso, ... Carcinogenesis 26 (12), 2095-2104, 2005 | 226 | 2005 |
DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients N García-Romero, J Carrión-Navarro, S Esteban-Rubio, E Lázaro-Ibáñez, ... Oncotarget 8 (1), 1416, 2017 | 224 | 2017 |
Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design G Castano-Vinyals, N Aragonés, B Pérez-Gómez, V Martín, J Llorca, ... Gaceta sanitaria 29, 308-315, 2015 | 208 | 2015 |
KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis P Cejas, M Lopez-Gomez, C Aguayo, R Madero, J de Castro Carpeno, ... PloS one 4 (12), e8199, 2009 | 197 | 2009 |
Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study AR de Molina, J Sarmentero-Estrada, C Belda-Iniesta, M Tarón, ... The lancet oncology 8 (10), 889-897, 2007 | 179 | 2007 |
Engineering iron oxide nanoparticles for clinical settings AL Cortajarena, D Ortega, SM Ocampo, A Gonzalez-García, P Couleaud, ... Nanobiomedicine 1, 2, 2014 | 159 | 2014 |
IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer I Ibanez de Caceres, M Cortes-Sempere, C Moratilla, R Machado-Pinilla, ... Oncogene 29 (11), 1681-1690, 2010 | 157 | 2010 |
Randomized, double-blind, placebo-controlled, multicenter phase II study of onartuzumab plus bevacizumab versus placebo plus bevacizumab in patients with recurrent glioblastoma … T Cloughesy, G Finocchiaro, C Belda-Iniesta, L Recht, AA Brandes, ... Journal of clinical oncology 35 (3), 343-351, 2017 | 135 | 2017 |
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer S Chattopadhyay, R Machado-Pinilla, C Manguan-García, ... Oncogene 25 (23), 3335-3345, 2006 | 116 | 2006 |
DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer V Moncho-Amor, I Ibañez de Cáceres, E Bandres, B Martinez-Poveda, ... Oncogene 30 (6), 668-678, 2011 | 114 | 2011 |
Cardiac toxicity: old and new issues in anti-cancer drugs M Sereno, A Brunello, A Chiappori, J Barriuso, E Casado, C Belda, ... Clinical and Translational Oncology 10, 35-46, 2008 | 103 | 2008 |
IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer M Cortes-Sempere, MP De Miguel, O Pernia, C Rodriguez, ... Oncogene 32 (10), 1274-1283, 2013 | 98 | 2013 |
Vesicle-mediated control of cell function: The role of extracellular matrix and microenvironment G Rackov, N Garcia-Romero, S Esteban-Rubio, J Carrión-Navarro, ... Frontiers in physiology 9, 651, 2018 | 89 | 2018 |
Cancer stem cells and cisplatin‐resistant cells isolated from non‐small‐lung cancer cell lines constitute related cell populations BD Lopez‐Ayllon, V Moncho‐Amor, A Abarrategi, II de Cáceres, ... Cancer medicine 3 (5), 1099-1111, 2014 | 88 | 2014 |